1: Rives ML, Shaw M, Zhu B, Hinke SA, Wickenden AD. State-Dependent Allosteric
Inhibition of the Human SLC13A5 Citrate Transporter by Hydroxysuccinic Acids,
PF-06649298 and PF-06761281. Mol Pharmacol. 2016 Dec;90(6):766-774. doi:
10.1124/mol.116.106575. Epub 2016 Oct 17. PMID: 27754898.
2: Pajor AM, de Oliveira CA, Song K, Huard K, Shanmugasundaram V, Erion DM.
Molecular Basis for Inhibition of the Na+/Citrate Transporter NaCT (SLC13A5) by
Dicarboxylate Inhibitors. Mol Pharmacol. 2016 Dec;90(6):755-765. doi:
10.1124/mol.116.105049. Epub 2016 Sep 28. PMID: 27683012.
3: Riccardi K, Li Z, Brown JA, Gorgoglione MF, Niosi M, Gosset J, Huard K, Erion
DM, Di L. Determination of Unbound Partition Coefficient and in Vitro-in Vivo
Extrapolation for SLC13A Transporter-Mediated Uptake. Drug Metab Dispos. 2016
Oct;44(10):1633-42. doi: 10.1124/dmd.116.071837. Epub 2016 Jul 14. PMID:
27417179.
4: Huard K, Gosset JR, Montgomery JI, Gilbert A, Hayward MM, Magee TV, Cabral S,
Uccello DP, Bahnck K, Brown J, Purkal J, Gorgoglione M, Lanba A, Futatsugi K,
Herr M, Genung NE, Aspnes G, Polivkova J, Garcia-Irizarry CN, Li Q, Canterbury
D, Niosi M, Vera NB, Li Z, Khunte B, Siderewicz J, Rolph T, Erion DM.
Optimization of a Dicarboxylic Series for in Vivo Inhibition of Citrate
Transport by the Solute Carrier 13 (SLC13) Family. J Med Chem. 2016 Feb
11;59(3):1165-75. doi: 10.1021/acs.jmedchem.5b01752. Epub 2016 Jan 27. PMID:
26734723.